| Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management KT Amber, DF Murrell, E Schmidt, P Joly, L Borradori Clinical reviews in allergy & immunology 54, 26-51, 2018 | 224 | 2018 |
| The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease KT Amber, M Valdebran, K Kridin, SA Grando Frontiers in medicine 5, 201, 2018 | 132 | 2018 |
| Unmet medical needs in chronic, non-communicable inflammatory skin diseases H Ujiie, D Rosmarin, MP Schön, S Ständer, K Boch, M Metz, M Maurer, ... Frontiers in medicine 9, 875492, 2022 | 113 | 2022 |
| Underlying systemic diseases in pyoderma gangrenosum: a systematic review and meta-analysis K Kridin, AD Cohen, KT Amber American journal of clinical dermatology 19, 479-487, 2018 | 107 | 2018 |
| Non-desmoglein antibodies in patients with pemphigus vulgaris KT Amber, M Valdebran, SA Grando Frontiers in immunology 9, 1190, 2018 | 106 | 2018 |
| Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid EH Kowalski, D Kneibner, K Kridin, KT Amber Autoimmunity reviews 18 (5), 526-534, 2019 | 99 | 2019 |
| Immune response in pemphigus and beyond: progresses and emerging concepts G Di Zenzo, KT Amber, BS Sayar, EJ Müller, L Borradori Seminars in immunopathology 38, 57-74, 2016 | 96 | 2016 |
| Epidermolysis bullosa acquisita: A comprehensive review K Kridin, D Kneiber, EH Kowalski, M Valdebran, KT Amber Autoimmunity Reviews 18 (8), 786-795, 2019 | 95 | 2019 |
| TNF‐α: a treatment target or cause of sarcoidosis? KT Amber, R Bloom, U Mrowietz, M Hertl Journal of the European Academy of Dermatology and Venereology 29 (11), 2104 …, 2015 | 86 | 2015 |
| Targeted therapies for autoimmune bullous diseases: current status KT Amber, R Maglie, F Solimani, R Eming, M Hertl Drugs 78, 1527-1548, 2018 | 83 | 2018 |
| Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris KT Amber, P Staropoli, MI Shiman, GW Elgart, M Hertl Experimental dermatology 22 (11), 699-704, 2013 | 83 | 2013 |
| Google search trends and skin cancer: evaluating the US population’s interest in skin cancer and its association with melanoma outcomes R Bloom, KT Amber, S Hu, R Kirsner JAMA dermatology 151 (8), 903-905, 2015 | 79 | 2015 |
| The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma K Amber, MP McLeod, K Nouri Dermatologic Surgery 39 (2), 232-238, 2013 | 77 | 2013 |
| Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus KT Amber, M Valdebran, SA Grando Autoimmunity Reviews 17 (10), 1002-1010, 2018 | 75 | 2018 |
| IgA pemphigus: A systematic review K Kridin, PM Patel, VA Jones, A Cordova, KT Amber Journal of the American Academy of Dermatology 82 (6), 1386-1392, 2020 | 72 | 2020 |
| BP180‐and BP230‐specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid? T Schmidt, C Sitaru, K Amber, M Hertl British Journal of Dermatology 171 (2), 212-219, 2014 | 69 | 2014 |
| The use of antioxidants in radiotherapy-induced skin toxicity KT Amber, MI Shiman, EV Badiavas Integrative cancer therapies 13 (1), 38-45, 2014 | 68 | 2014 |
| An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab KT Amber, M Hertl Journal of the European Academy of Dermatology and Venereology 29 (4), 777-782, 2015 | 65 | 2015 |
| A review comparing international guidelines for the management of bullous pemphigoid, pemphigoid gestationis, mucous membrane pemphigoid, and epidermolysis bullosa acquisita PM Patel, VA Jones, TN Murray, KT Amber American Journal of Clinical Dermatology 21 (4), 557-565, 2020 | 62 | 2020 |
| A review of the use of topical calendula in the prevention and treatment of radiotherapy-induced skin reactions J Kodiyan, KT Amber Antioxidants 4 (2), 293-303, 2015 | 59 | 2015 |
